Identified risk factors for ischemic digital loss include the diffuse subtype of SSc, SSc specific antibodies (anti-centromere antibodies and anti-topoisomerase antibodies), current smoking, anti-beta2-glycoprotein I antibodies, and anti-granzyme B antibodies. Here, GZMB is linked to systemic sclerosis.